Substance / Medication

Clarithromycin

Overview

Active Ingredient
clarithromycin
RxNorm CUI
21212
Labeler: A-S Medication SolutionsUpdated: 2026-02-19T00:00:00.000ZFull label on DailyMed

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

58 trials linked to this intervention

58
Total Trials
7
Recruiting
4
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Accuracy of Fecal Polymerase Chain Reaction Testing in Clarithromycin-Resistant Helicobacter Pylori: A Systematic Review and Meta-Analysis.
Al Qady Ahmed, Aldhaleei Wafa, Salih Mohamed et al. · Clin Transl Gastroenterol · 2025
PMID: 39620581Meta-AnalysisFull text (PMC)
Clarithromycin-resistant Helicobacter pylori in Africa: a systematic review and meta-analysis.
Dossouvi Komla Mawunyo, Bouyo Tchilabalo, Sognonnou Simon et al. · Antimicrob Resist Infect Control · 2025
PMID: 40221805Meta-AnalysisFull text (PMC)
Global Estimate of Clarithromycin Resistance in Clinical Isolates of Helicobacter pylori: a Systematic Review and Meta-Analysis.
Khoshnood Saeed, Pakzad Reza, Kaviar Vahab Hassan et al. · Clin Lab · 2023
PMID: 37436391Meta-Analysis
The prevalence of clarithromycin-resistantisolates: a systematic review and meta-analysis.
Sholeh Mohammad, Khoshnood Saeed, Azimi Taher et al. · PeerJ · 2023
PMID: 37016679Meta-AnalysisFull text (PMC)
Heteroresistance to clarithromycin and metronidazole in patients with a Helicobacter pylori infection: a systematic review and meta-analysis.
Kouhsari Ebrahim, Sadeghifard Nourkhoda, Khadiv Arezoo et al. · Ann Clin Microbiol Antimicrob · 2022
PMID: 35596211Meta-AnalysisFull text (PMC)
Clarithromycin as an adjunct to periodontal therapy: a systematic review and meta-analysis.
Bashir Nasir Zeeshan, Sharma Praveen · Int J Dent Hyg · 2022
PMID: 33773046Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Clarithromycin (substance)
SNOMED CT
387487009
UMLS CUI
C0055856
RxNorm CUI
21212
Labeler
A-S Medication Solutions

Clinical Data

This intervention maps to 16 entities in the Healos knowledge graph.

16
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
58
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.